Pentraxin-3 Is Not Related to Disease Severity in Cirrhosis and Hepatocellular Carcinoma Patients

Clinical and Experimental Medicine- Italy

doi 10.1007/s10238-020-00617-4

Full Text

Abstract

Available in

Categories

Molecular Biology

Date

February 20, 2020

Authors

Elisabeth M. Haberl

Thomas S. Weiss

Christa Buechler

Publisher

Springer Science and Business Media LLC

Related search

Plasma Pentraxin 3 Is Associated With Cardiovascular Disease in Hemodialysis Patients

Intensive Care Medicine

English

Surveillance for Hepatocellular Carcinoma Secondary to Cardiogenic Cirrhosis in Patients With Congenital Heart Disease

Clinical Research in Cardiology

Cardiovascular Medicine

English

Hepatocellular Carcinoma Complicating Hepatitis E Virus-Related Cirrhosis

Portuguese

Profiling of Plasma Metabolomics in Patients With Hepatitis C-Related Liver Cirrhosis and Hepatocellular Carcinoma

Clinical and Experimental Hepatology

English

Effectiveness of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis

Cancer Epidemiology Biomarkers and Prevention

English

CD14+ Regulatory Dendritic Cells in Patients With Hepatocellular Carcinoma and Cirrhosis

English

RE: No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis

Gastroenterology

Gastroenterology

English

Laparoscopic Hepatectomy for Hepatocellular Carcinoma in Patients With Liver Cirrhosis

Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)

English

Cost-Effectiveness of Antiviral Treatment After Resection in HBV-related Hepatocellular Carcinoma Patients With Compensated Cirrhosis

English